Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Navigate: Correlations HPO
There is one clinical trial.
Clinical research study that evaluates the effect of Turkish Beam-Selective UV developed by RD GLOBAL ARAŞTIRMA GELİŞTİRME SAĞLIK İLAÇ İNŞAAT YATIRIMLARI A.Ş. use into Intravascular, Intrapulmonary, Intratracial, Intrarespiratory area. Bacteria, Fungal and Virus-based pathogens systematically to collect and evaluate specific clinical performance and safety data. This Clinical Research aims to investigate the effectiveness of the treatment group and control group mortality rates, intensive care hospitalization times, monitoring the virus load by PCR, and the treatment effectiveness of UVC application. This Clinical Research covers determining the treatment effectiveness and reliability of UVC application to patient groups, the details of which are determined in the protocol.
Description: viral load measurement due to covid 19,
Measure: PCR Sampling Time: up to 15 daysDescription: Change from reference range in blood urea (mg/dL)
Measure: Blood Tests Time: up to 15 daysDescription: Change from reference range in blood Creatinine (mg/dL)
Measure: Blood Tests Time: up to 15 daysDescription: Change from reference range in blood AST,ALT (U/L)
Measure: Blood Tests Time: up to 15 daysDescription: Change from reference range in Complete blood count (sodium, potassium mol/L)
Measure: Blood Tests Time: up to 15 daysDescription: Change from reference range in Complete blood count (total bilirubin mg/dL)
Measure: Blood Tests Time: up to 15 daysDescription: Change from reference range in Complete blood CRP (mg/L)
Measure: Blood Tests Time: up to 15 daysDescription: Change from reference range in Complete blood creatine kinase (IU/L)
Measure: Blood Tests Time: up to 15 daysDescription: Change from reference range in Complete blood LDH (U/L)
Measure: Blood Tests Time: up to 15 daysDescription: Change from reference range in Complete blood APTT (sec)
Measure: Blood Tests Time: up to 15 daysDescription: Change from reference range in Complete blood D-Dimer (ng/ml)
Measure: Blood Tests Time: up to 15 daysDescription: Change from reference range in Complete blood Ferritin (ug/L)
Measure: Blood Tests Time: up to 15 daysDescription: Radiological findings: Consolidation, ground glass appearance and reticulo-nodular opacity appearance in lung CT.
Measure: Radiological Imaging Time: up to 15 daysDescription: Radiological findings: reticulo-nodular opacity appearance in lung CT.
Measure: Radiological Imaging Time: up to 15 daysDescription: Radiological findings: ground glass appearance in lung CT.
Measure: Radiological Imaging Time: up to 15 daysDescription: Radiological findings: Consolidation in lung CT.
Measure: Radiological Imaging Time: up to 15 daysAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports